Compare IMVT & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMVT | EAT |
|---|---|---|
| Founded | 2018 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 9.5B |
| IPO Year | 2019 | 1994 |
| Metric | IMVT | EAT |
|---|---|---|
| Price | $37.70 | $217.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 21 |
| Target Price | $33.00 | ★ $183.00 |
| AVG Volume (30 Days) | ★ 1.1M | 817.7K |
| Earning Date | 05-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.65 |
| EPS | N/A | ★ 10.87 |
| Revenue | N/A | ★ $5,807,400,000.00 |
| Revenue This Year | N/A | $9.00 |
| Revenue Next Year | N/A | $5.49 |
| P/E Ratio | ★ N/A | $19.55 |
| Revenue Growth | N/A | ★ 7.86 |
| 52 Week Low | $14.58 | $100.30 |
| 52 Week High | $45.42 | $254.99 |
| Indicator | IMVT | EAT |
|---|---|---|
| Relative Strength Index (RSI) | 31.10 | 40.35 |
| Support Level | $23.66 | $131.01 |
| Resistance Level | $41.22 | $254.35 |
| Average True Range (ATR) | 1.42 | 7.69 |
| MACD | -0.66 | -4.46 |
| Stochastic Oscillator | 0.00 | 5.13 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.